Skip to main content
SpringerLink
Log in

Female Genital System

  • Chapter
Anatomic Basis of Tumor Surgery

Abstract

The incidence of gynecologic malignancies as a group have an incidence second only to to breast cancer. In the year 2009, approximately 192,370 new female breast cancers will be diagnosed compared to 80,720 gynecologic malignancies (cervix, 11,270; corpus uteri, 42,160; ovary, 21,550, vulva 3,580; other, 2,160). Gynecologic malignancies ranked third in estimated female cancer deaths in 2009: lung/bronchus, 70,490; breast, 40,170; and gynecologic, 28,120 (cervix, 4,070; corpus uteri, 7,780; ovary, 14,600; vulva, 900; other, 820). The incidence of cervical cancer has markedly decreased over the last 50 years with Papanicolaou (Pap) smear screening and colposcopy. Endometrial carcinoma has also decreased as a result of the changes in prescribed hormone supplementation. Unopposed, estrogens were responsible for a significant number of well-differentiated carcinomas in the menopausal patient. The addition of progesterone and liberal indications of endometrial biopsy have assisted in decreasing the incidence. In the uterus, tamoxifen is an estrogen agonist, whereas it is an antagonist in the breast. Uterine stimulation is present with patients receiving tamoxifen to treat breast cancer. All abnormal bleeding in this group of patients is a suspect for the presence of endometrial cancer. Endometrial biopsies are required to rule out this malignancy in menopausal patients with abnormal bleeding. Early diagnosis of ovarian cancer is difficult. Screening ultrasonography and CA-125 have low sensitivity and specificity when used to diagnose occult ovarian malignances in the asymptomatic patient. As a result, even in initial examination these patients have advanced disease, with high mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Readings

  • Adam RA, Kovac SR. Diagnosis and treatment of fistulas. In: Bieber EJ, Sanfilippo SJ, Horowitz IR, editors. Clinical Gynecology. 1st ed. Philadelphia, PA: Elsevier. 2006

    Google Scholar 

  • American Cancer Society, Cancer Facts &Figures, 2008. www.cancer.org

  • Horowitz IR, editor. Clinical gynecology. 1st ed. Philadelphia, PA: Churchill Livingstone, Elsevier; 2006. p. 413 –41

    Google Scholar 

  • Horowitz IR. Urinary tract injuries. In: Kovac SR, Zimmerman C, editors. Textbook of vaginal surgery. Philadelphia: Lippincott; 2006

    Google Scholar 

  • Netter FH. The CIBA collection of medical illustrations, vol 2. Reproductive system. New York: RR Donnelley; 1984

    Google Scholar 

  • Thompson JD. Operative injuries to the ureter: prevention, recognition and management. In: Rock JA, Jones HW III, editors. TeLinde 's operative gynecology. 10th ed. Philadelphia, PA: Lippincott-Raven; 2008. p. 1135 –74

    Google Scholar 

  • Thompson JD. Vesicovaginal and urethrovaginal fistulas. In: Rock JA, Jones HW III, editors. TeLinde 's operative gynecology. 10th ed. Philadelphia, PA: Lippincott-Raven; 2008. p. 1175 –206

    Google Scholar 

Uterine Cancer

  • Bloss JD, Berman ML, Bloss LP, et al Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patient. Gynecol Oncol. 1991;40:74

    Article  PubMed  CAS  Google Scholar 

  • Cilby WA, Clarke-Pearson DL, Dodge R, et al Acute morbidity and mortality associated with selective pelvic and ara-aortic lymphadenectomy in the surgical staging of endometrial carcinoma. J Gynecol Tech. 1995;1:19–26

    Google Scholar 

  • Creasman WT, Morrow CP, Bundy BN, et al Surgical pathologic spread patterns of endometrial cancer. Cancer 1987;60:2035 –41

    Article  PubMed  CAS  Google Scholar 

  • Currie JL. Malignant tumors of the uterine corpus. In: Rock JA, Jones HW III, editors. TeLinde 's operative gynecology. 10th ed. Philadelphia, PA: Lippincott-Raven; 2008. p. 1501–56

    Google Scholar 

  • Hacker NF. Uterine cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 2nd ed. Baltimore: Williams &Wilkins; 1994. p. 285–326

    Google Scholar 

  • Hernandez E, Houck KL. Endometrial carcinoma. In: Bieber EJ, Sanfilippo SJ, Horowitz IR, editors. Clinical Gynecology. 1st ed. Philadelphia, PA: Elsevier. 2006

    Google Scholar 

  • Horowitz IR, editors. Clinical gynecology. 1st ed. Philadelphia, PA: Churchill Livingstone, Elsevier; 2006. p. 665–75

    Google Scholar 

  • Horowitz IR, De La Cuesta RS. Benign and malignant tumors of the ovary. In: Carpenter SEK, Rock JA, editors. Pediatric and adolescent gynecology. New York: Raven; 1992

    Google Scholar 

  • Horowitz IR, Shingleton HM. The role of chemotherapy and radiotherapy in the treatment of endometrial carcinoma. Curr Obstet Gynaecol. 1997;7:22–9

    Article  Google Scholar 

  • Hricak H, Burinstein LV, Gerhman GM, et al MR imaging evaluation of endometrial carcinoma: results of an NCI Cooperative Study. Radiology 1991;179:829

    PubMed  CAS  Google Scholar 

  • Kaminski PF, Podczaski ES. Benign conditions of the uterus. In: Hernandez E, Atkinson BF, editors. Clinical gynecologic pathology. Philadelphia, PA: WB Saunders; 1995. p. 223 –86

    Google Scholar 

  • Lurain JR. The significance of positive peritoneal cytology in endometrial cancer. Gynecol Oncol. 1992;46:143

    Article  PubMed  CAS  Google Scholar 

  • Maggino T, Romagnolo C, Candoni F, et al An analysis of the approaches to the management of endometrial cancer in North America. Gynecol Oncol. 1998;68:274–79

    Article  PubMed  CAS  Google Scholar 

  • Mariani A, Webb MJ, Keeney GL, et al Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182:1506–19

    Article  PubMed  CAS  Google Scholar 

  • Mariani A, Webb MJ, Keeney GL, et al The role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol. 2001;83:72–80

    Article  PubMed  CAS  Google Scholar 

  • Morrow CP, Bundy BN, Kurman RJ, et al Relationship between surgical-pathologic risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55

    Article  PubMed  CAS  Google Scholar 

  • Rose PG. Endometrial carcinoma. N Engl J Med. 1996;335:640–9

    Article  PubMed  CAS  Google Scholar 

  • Shingleton HM, Thompson JD. Cancer of the cervix. In: Rock JA, Jones HW III, editors. TeLinde 's operative gynecology. 10th ed. Philadelphia, PA: Lippincott-Raven; 2008. p. 1413–500

    Google Scholar 

  • Soto-Wright S, McLellan R. Uterine sarcomas. In: Hernandez E, Houck KL, editors. Endometrial carcinoma In: Bieber EJ, Sanfilippo SJ, Horowitz IR, editors. Clinical gynecology. 1st ed. Philadelphia, PA: Churchill Livingstone, Elsevier; 2006. p. 677–85

    Google Scholar 

Cervical Cancer

  • Almeida-Parra Z, Penalver M, Mendez LE. Cervical carcinoma. In: Bieber EJ, Sanfilippo SJ, Horowitz IR, editors. Clinical gynecology, 1st ed. Philadelphia, PA: Churchill Livingstone, Elsevier; 2006. p. 651 –63

    Google Scholar 

  • Atypical squamous cells of undetermined significance/Low-grade squamous intraepithelial lesions Triage Study (ALTS) Group: Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions. J Natl Cancer Inst. 2000;92:397–402

    Article  Google Scholar 

  • Bachsbaum JH, Lifshitz S. The role of scalene lymph node biopsy in advanced carcinoma of the cervix uteri. Surg Gynecol Obstet. 1976;143:246

    Google Scholar 

  • Hatch KD. Cervical cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 2nd ed. Baltimore: Williams &Wilkins; 1994. p. 243–84

    Google Scholar 

  • Hatch KD, Parham G, Shingleton HM, et al Ureteral strictures and fistulae following radical hysterectomy. Gynecol Oncol. 1984;19:17

    Article  PubMed  CAS  Google Scholar 

  • Perez CA, Grigsby PW, Camel HM, et al Irradiations alone or combined with surgery in stage Ib IIA and IIB carcinoma of uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 1995;31:703–16

    Article  PubMed  CAS  Google Scholar 

  • Piver M, Rutledge F, Smith J. Five classes of extended hystrectomy for women with cervical cancer. Obstet Gynecol. 1974;44:265

    PubMed  CAS  Google Scholar 

  • Samlal RAK, van der Velden J, Ketting BW, et al Disease-free interval and recurrence pattern after the Okabayashi variant of Wertheim 's radical hysterectomy for stage Ib and IIA cervical carcinoma. Int J Gynecol Cancer. 1996;6:120–7

    Article  Google Scholar 

  • Weiser GB, Bundy BN, Hoskins WJ, et al Extraperitoneal vs transperitoneal selective paraaortic lymph-adenectomy in the pretreatment surgical staging of advanced cervical carcinoma (GOG Study). Gynecol Oncol. 1989;33:283

    Article  PubMed  CAS  Google Scholar 

Ovarian Cancer

  • Abu-Rustum NR, Aghajanian C. Management of malignant germ cell tumors of the ovary. Semin Oncol. 1998;25:235–42

    PubMed  CAS  Google Scholar 

  • Berek JS. Epithelial ovarian cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 2nd ed. Baltimore: Williams &Wilkins; 1994. p. 327–76

    Google Scholar 

  • Berek JS, Griffith CT, Leventhal JM. Laparoscopy for second-look evaluation in ovarian cancer. Obstet Gynecol. 1981;58:192

    PubMed  CAS  Google Scholar 

  • Bristow RE, Tomacruz RS, Armstrong DK, et al Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59

    Article  PubMed  Google Scholar 

  • Deppe G, Malviya VK, Boike G, et al Use of cavitron surgical aspirator for debulking of diaphragmatic metastases in patients with advanced carcinoma of the ovaries. Surg Gynecol Obstet. 1989;168:458

    Google Scholar 

  • DuPont J. Management of ovarian cancer: balancing medical and quality of life. Oncol Spec Ed. 2004;7:191–8

    Google Scholar 

  • Hoskins WJ, Bundy BN, Thigpen TJ, et al The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 1992;47:159

    Article  PubMed  CAS  Google Scholar 

  • Hoskins WJ, McGuire WP, Brady MF, et al The effect of diameter of largest residual disease on survival, after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994;170:974–80

    PubMed  CAS  Google Scholar 

  • Hunter RW, Alexander NDE, Soutter WP. Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol. 1992;166:504

    PubMed  CAS  Google Scholar 

  • McGuire WP, Hoskins WJ, Brady MF, et al A phase III trial comparing cisplatin/cytoxan (PC) and cisplatin/taxol (PT) in advanced ovarian cancer. Proc Am Soc Clin Oncol. 1993;29:808

    Google Scholar 

  • Omura GA, Brady MF, Homesley HD, et al Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol. 1991;9:1138

    PubMed  CAS  Google Scholar 

  • Piver MS, Hempling RE. Ovarian cancer: etiology, screening, prophylactic oophorectomy, and surgery. In: Rock JA, Thompson JD, editors. TeLinde 's operative gynecology. 8th ed. Philadelphia: Lippincott-Raven; 1997. p. 1557–68

    Google Scholar 

  • Rubin SC, Hoskins WJ, Hakes TB, et al Recurrence after negative second-look lap-arotomy for ovarian cancer: analysis of risk factors. Am J Obstet Gynecol. 1988;159:1094

    PubMed  CAS  Google Scholar 

  • Uyar D, Rose PG. Ovarian carcinoma. In: Bieber EJ, Sanfilippo SJ, Horowitz IR, editors. Clinical gynecology. 1st ed. Philadelphia, PA: Churchill Livingstone, Elsevier; 2006. p. 699–710

    Google Scholar 

  • Van der Burg ME, van Lent M, Buyse M, et al The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med. 1995;332:629–34

    Article  PubMed  Google Scholar 

Vulvar Cancer

  • Berek JS, Heaps JM, Fu YS, et al Concurrent cisplatin and 5-fluorouracil chemotherapy and radiotherapy for advanced stage squamous carcinoma of the vulva. Gynecol Oncol. 1991;42:197

    Article  PubMed  CAS  Google Scholar 

  • Buchanan DJ, Schlaerth J, Kurosaki T. Primary vaginal melanoma: thirteen-year disease-free survival after wise local excision and review of recent literature. Am J Obstet Gynecol. 1998;178:1177

    Article  PubMed  CAS  Google Scholar 

  • Burke TW, Stringer CA, Gershenson DM, et al Radical wide excision and selective inguinal node dissection of squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38:328

    Article  PubMed  CAS  Google Scholar 

  • Daling JR, Madeleine MM, Schwartz SM, et al A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol. 2002;84:263

    Article  PubMed  CAS  Google Scholar 

  • Gordon AN. Vulvar carcinoma. In: Bieber EJ, Sanfilippo SJ, Horowitz IR, editors. Clinical gynecology. 1st ed. Philadelphia, PA: Churchill Livingstone, Elsevier; 2006. p. 631–42

    Google Scholar 

  • Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 2nd ed. Baltimore: Williams &Wilkins; 1994. p. 403–40

    Google Scholar 

  • Hacker NF, Berek JS, Lagasse LD, et al Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol. 1984;63:155

    PubMed  CAS  Google Scholar 

  • Hacker NF, Leuchter RS, Berek JS, et al Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574

    PubMed  CAS  Google Scholar 

  • Homesley HD, Bundy BN, Sedlis A, et al Radiation therapy vs pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68:733

    PubMed  CAS  Google Scholar 

  • Rotmensch J, Rubin SJ, Sutton HG, et al Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas. Gynecol Oncol. 1990;36:181

    Article  PubMed  CAS  Google Scholar 

  • Stehman F, Bundy N, Bell J, et al Groin dissection vs groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 1992;24:389

    Article  PubMed  CAS  Google Scholar 

  • Stehman FB, Bundy B, Droretsky PM, et al Early stage I carcinoma of the vulva treated ith ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group Obstet Gynecol 1992;79–490

    PubMed  CAS  Google Scholar 

  • Taussig FJ. Cancer of the vulva: an analysis of 155 cases. Am J Obstet Gynecol. 1940;40:764

    Google Scholar 

  • Way S. Carcinoma of the vulva. Am J Obstet Gynecol. 1960;79:692

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Emory University School of Medicine, Woodruff Memorial Building, Room 4307, Atlanta, GA, 30322, USA

    Ira R. Horowitz (Willaford Ransom Leach Professor of Gynecology and Obstetrics and Director, Member, Chief Medical Officer)

  2. Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA

    Ira R. Horowitz (Willaford Ransom Leach Professor of Gynecology and Obstetrics and Director, Member, Chief Medical Officer)

  3. Emory University Hospital, Atlanta, GA, 30322, USA

    Ira R. Horowitz (Willaford Ransom Leach Professor of Gynecology and Obstetrics and Director, Member, Chief Medical Officer)

Authors
  1. Ira R. Horowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ira R. Horowitz .

Editor information

Editors and Affiliations

  1. Department of Surgery, Emory University School of Medicine, 1365 Clifton Road, Atlanta, GA, 30322, USA

    William C. Wood

  2. Division of Surgical Oncology, Emory University School of Medicine, 1364 Clifton Road, Atlanta, GA, 30322, USA

    Charles A. Staley

  3. Centers for Surgical Anatomy and Technique, Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA, 30322, USA

    John E. Skandalakis

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Horowitz, I.R. (2010). Female Genital System. In: Wood, W.C., Staley, C.A., Skandalakis, J.E. (eds) Anatomic Basis of Tumor Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74177-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-74177-0_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-74176-3

  • Online ISBN: 978-3-540-74177-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation